- Home
- HURA
HURA
TuHURA Biosciences Inc. Common Stock
as 05-15-2025 4:00pm EST
Stocks
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | TAMPA |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $11.50 | AVG Volume (30 days): | 115.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.21 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.80 - $14.60 | Next Earning Date: | 05-27-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | -68.95% | Revenue Growth (next year): | 69.15% |
Latest TuHURA Biosciences Inc. Common Stock News
HURA Breaking Stock News: Dive into HURA Ticker-Specific Updates for Smart Investing
PR Newswire
2 days ago
TuHURA Biosciences, Inc. to Present at the 3rd Annual H.C. Wainwright BioConnect Conference
PR Newswire
10 days ago
TuHURA Biosciences, Inc. Initiates Phase 1b/2a Study of IFx-Hu2.0 as an Adjunctive Therapy to Keytruda® (pembrolizumab) in First Line Treatment for Metastatic Merkel Cell Carcinoma of Unknown Primary Origin (MCCUP)
MT Newswires
17 days ago
TuHURA Biosciences Reports Cancer Immunotherapy Safe, Well Tolerated in Clinical Trial
PR Newswire
17 days ago
TuHURA Biosciences and Kineta Present Updated Results from Kineta's Phase I-II Study of KVA12123 and TuHURA's Mechanism of IFx-Hu2.0 Responses After Anti-PD-1 Therapy Failure in Advanced Melanoma at the American Association for Cancer Research Annual Meeting
Insider Monkey
a month ago
Is TuHURA Biosciences, Inc. (HURA) the Best Rising Penny Stock to Buy According to Analysts?
Zacks Small Cap Research
a month ago
HURA: 2024 Financial Results
PR Newswire
a month ago
TuHURA Biosciences, Inc. Announces Abstracts Accepted for Poster Presentation at the 2025 AACR Annual Meeting
PR Newswire
a month ago
TuHURA Biosciences, Inc. Appoints Dr. Bertrand Le Bourdonnec as Executive Vice President, Head of Drug Discovery, Early Development, and Program Management
Compare HURA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HURA TuHURA Biosciences Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.